139 related articles for article (PubMed ID: 6265217)
1. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
Fogelman I; Bessent RG
Eur J Nucl Med; 1981; 6(5):235. PubMed ID: 6265217
[No Abstract] [Full Text] [Related]
2. Accumulation of Tc-99m phosphorus compounds in medullary carcinoma of the thyroid: report of two cases.
Shigeno C; Fukunaga M; Yamamoto I; Dokoh S; Morita R; Hino M; Torizuka K
Clin Nucl Med; 1982 Jun; 7(6):297-8. PubMed ID: 6282522
[No Abstract] [Full Text] [Related]
3. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
[No Abstract] [Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of electrocardiography and myocardial scintigraphy with 99m Tc-Sn-pyrophosphate and 99m Tc-Sn-phosphone in patients with stenocardia].
Zudbinov IuI; Ponomareva AG; Sokolov OK
Med Radiol (Mosk); 1986 Aug; 31(8):22-6. PubMed ID: 3091990
[TBL] [Abstract][Full Text] [Related]
7. Effect of EHDP on calcium accumulation and technetium-99m pyrophosphate uptake in experimental myocardial infarction.
Buja LM; Tofe AJ; Parkey RW; Francis MD; Lewis SE; Kulkarni PV; Bonte FJ; Willerson JT
Circulation; 1981 Nov; 64(5):1012-7. PubMed ID: 6269777
[No Abstract] [Full Text] [Related]
8. Time course of 99mTc-pyrophosphate and 99mTc-gluconate uptake in experimental ischaemic myocardial necrosis.
Kasalický J; Riedel A; Konopková M
Radiobiol Radiother (Berl); 1985; 26(5):641-50. PubMed ID: 3003790
[No Abstract] [Full Text] [Related]
9. The bone scan as a tumour marker in prostatic carcinoma.
Chisholm GD; Stone AR; Beynon LL; Merrick MV
Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of pyrophosphate and gluconate scans of the heart in dogs with experimental cardiomyopathy].
Duska F; Novák J; Kafka P; Kubícek J; Vizd'a J; Mazurová Y; Veverková O
Vnitr Lek; 1983 Apr; 29(4):338-44. PubMed ID: 6306923
[No Abstract] [Full Text] [Related]
11. Radiopharmaceuticals for myocardial infarct imaging: a clinical comparison of 99Tcm-pyrophosphate and 99Tcm-dimethylaminomethylene diphosphonate.
Bell D; Millar AM; Grayshan R; Muir AL
Br J Radiol; 1988 Jul; 61(727):646-8. PubMed ID: 2841991
[No Abstract] [Full Text] [Related]
12. [Comparison of the pyrophosphate and gluconate cardiac scan in the diagnosis of experimental pericarditis in dogs].
Duska F; Novák J; Vizda J; Kafka P; Mazurová Y; Kubícek J
Cas Lek Cesk; 1983 Sep; 122(36):1093-6. PubMed ID: 6313197
[No Abstract] [Full Text] [Related]
13. Re: Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.
Moinuddin M
J Nucl Med; 1980 Jan; 21(1):103. PubMed ID: 6243351
[No Abstract] [Full Text] [Related]
14. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
Halpern SE; Hagan PL; Chauncey DM; Ayers P
Eur J Nucl Med; 1980 Dec; 5(6):515-9. PubMed ID: 6257523
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of the gluconate and pyrophosphate heart scan in the diagnosis of acute transmural myocardial infarctions].
Duska F; Kubícek J; Novák J; Vizdá J; Kafka P; Bastecký J
Cesk Radiol; 1982 Nov; 36(6):402-9. PubMed ID: 6297812
[No Abstract] [Full Text] [Related]
16. Clinical evaluation of positive myocardial imaging.
Hale TI; Jucker A
Eur J Nucl Med; 1984; 9(11):525-6. PubMed ID: 6097450
[No Abstract] [Full Text] [Related]
17. [A comparison of the pyrophosphate and glucoheptonate heart scan in 3 women with secondary cardiomyopathy (a preliminary report)].
Duska F; Novák J; Kafka P; Vizd'a J; Bradna P
Vnitr Lek; 1982 Jul; 28(7):661-4. PubMed ID: 6287727
[No Abstract] [Full Text] [Related]
18. Evaluation of [99mTc]N-phosphorylaminoethyl-phosphate [( 99mTc]PAEP) as imaging agent in acute myocardial infarction.
Chiotellis E; Varvarigou A; Smirniotis B; Papadimitriou J
Int J Nucl Med Biol; 1984; 11(3-4):280-2. PubMed ID: 6099342
[No Abstract] [Full Text] [Related]
19. A patient with primary hyperparathyroidism and an abnormal bone scan.
van Leendert RJ; Flendrig JA
Clin Nucl Med; 1986 Oct; 11(10):701-3. PubMed ID: 3021369
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-aminohexylidendiphosphonate and 99mTc-pyrophosphate in the scintigraphic diagnosis of experimental myocardial infarction in dogs.
Duska F; Hadas L; Vizda J; Kafka P; Urbanová E; Palicka V; Mazurová Y; Kuba M; Grossman V
Nuklearmedizin; 1988 Oct; 27(5):226-7. PubMed ID: 2848225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
